Results Presentation
3Q FY Ending March 2024
WIN-Partners Co., Ltd. (3183)

3Q results to December 2023

Highlights⚫ The number of cases in major segments increased YoY⚫ Gross profit increased YoY due to sales volume
increase, trading margin expansion, reinforced rebateprograms, etc.

⚫ SGA expenses increased due to new consolidations,increased labor and operational costs, and one-offexpenses, resulting in operating profit down YoY

3

Consolidated results summary（¥ mil.）3Q toDec. 2022

Dec. 2023

YoY (%)

Sales

51,352+6.9

Operating profit

1,800

Recurring profit

1,803

Net profit

1,551

EPS (yen)

54.59

54,894
1,693
1,700
1,198
42.08

BPS (yen)784.05795.08

-5.9
-5.7
-22.7
－－4

SalesYoY+6.9%(¥ mil.)51,35254,894

3Q to Dec. 2022

3Q to Dec. 2023

⚫ Sales of major segments increased YoY due to anincrease in the number of cases⚫ Sales at existing major customers increased⚫ Sales of CRS recovered in Q3⚫ Sales related to ablation and Structural Heart Disease(SHD) continued to grow5

Sales breakdown by segment (YoY)
SegmentSales（¥ mil.）YoY growth (%)
VolumeValue% of sales(%)

Percutaneous coronary intervention (PCI)

12,848+3.2+4.7

23.4

Cardiac rhythm segment (CRS)

13,950+1.2+2.9

25.4

Cardiac vascular segment (CVS)9,555+5.8+18.6

17.4

Percutaneous peripheral intervention (PPI)

3,208+10.1+10.8

5.8

Neurovascular

2,780+18.9+16.8

5.1

Diabetes mellitus segment (DMS)

2,677-+8.2

4.9

Medical equipment

5,203--4.0

9.5

Others4,669-+8.5

8.5

54,894-

+6.9

100.0

Total6

Operating profit
YoY-5.9%(¥ mil.)

1,800

1,693

3Q to Dec. 2022

3Q to Dec. 2023

⚫ Gross profit margin 12.3% (+0.1 pp YoY)
- Increase in sales volume- Expansion in trading margins- Reinforcement of the rebate programs⚫ SGA +13.9% YoY- Consolidations of TO-SAY Medical and TRYTECH- Increase in labor costs and other expenses (+11.6% and +20.1% respectively)- 10th anniversary-related expenses- Number of employees: 611 (Dec. 2022) → 627 (Dec. 2023)

7

Net profit
YoY-22.7%(¥ mil.)1,5511,198
3Q to Dec. 2022

3Q to Dec. 2023

⚫ Absence of profit from fixed asset sale8

Disclaimer
This material was prepared based on the information available and the views held at the time it was made. Statements in thismaterial that are not historical facts, including but not limited to plans, forecasts and strategies are “forward-looking statements.”
Forward-looking statements are by their nature subject to various risks and uncertainties, including but not limited to a decline ingeneral economic conditions, general market conditions, technological developments, changes in customer demand for products
and services, increased competition, and other important factors, each of which may cause actual results and future developments
to differ materially from those expressed or implied in any forward-looking statement.
With the passage of time, the information in this material (including but not limited to forward-looking statements) could besuperseded or cease to be accurate. WIN-Partners Co., Ltd. disclaims any obligation or responsibility to update, revise, orsupplement any forward-looking statement or other information in any material or generally to any extent. The utilization of orreliance on the information in this material is at your own risk.

ContactWIN-Partners Co., Ltd.
Investor Relations
Phone: +81-3-3548-0790
https://www.win-partners.co.jp/en/

Click here for thehomepage →